CymitQuimica logo
Apoptose

Apoptose

Les inhibiteurs de l'apoptose sont des composés qui empêchent ou retardent le processus de mort cellulaire programmée, connu sous le nom d'apoptose. Ces inhibiteurs sont essentiels pour étudier les mécanismes de survie cellulaire et sont utilisés pour enquêter sur les maladies où l'apoptose est dysrégulée, telles que le cancer, les troubles neurodégénératifs et les maladies auto-immunes. En modulant l'apoptose, ces inhibiteurs peuvent aider au développement de thérapies visant à contrôler la mort cellulaire. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de l'apoptose de haute qualité pour soutenir vos recherches en biologie cellulaire, oncologie et domaines connexes.

Sous-catégories appartenant à la catégorie "Apoptose"

Affichez 6 plus de sous-catégories

6068 produits trouvés pour "Apoptose"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • PI3Kα-IN-8


    PI3Kα-IN-8 is a selective inhibitor of PI3Kα (IC50: 0.012 μM).
    Formule :C26H27BrN4O2
    Couleur et forme :Solid
    Masse moléculaire :507.42

    Ref: TM-T63477

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Spicamycin

    CAS :
    Spicamycin can be used as a potent inducer of differentiation of human myeloid leukemia cells (HL-60) and murine myeloid leukemia cells (M1).
    Formule :C30H51N7O7
    Couleur et forme :Solid
    Masse moléculaire :621.77

    Ref: TM-T34694

    25mg
    5.291,00€
    50mg
    7.012,00€
    100mg
    10.070,00€
  • MTX-216

    CAS :
    MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research.
    Formule :C22H14Cl2FN5O2S
    Couleur et forme :Solid
    Masse moléculaire :502.348

    Ref: TM-T206251

    10mg
    À demander
    50mg
    À demander
  • PD-1-IN-17 TFA


    PD-1-IN-17 TFA is a potent PD-1 inhibitor, blocking 92% of splenocyte growth at 100 nM.
    Formule :C15H23F3N6O9
    Couleur et forme :Solid
    Masse moléculaire :488.37

    Ref: TM-T63256

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • MJC13

    CAS :
    <p>MJC13 is an FKBP52-targeting agent with antitumor activity, suitable for prostate cancer research.</p>
    Formule :C13H15Cl2NO
    Couleur et forme :Solid
    Masse moléculaire :272.17

    Ref: TM-T204886

    10mg
    À demander
    50mg
    À demander
  • CDK2/9-IN-1

    CAS :
    CDK2/9-IN-1 (compound 20a) is an orally active dual inhibitor of CDK2 and CDK9, with IC50 values of 0.004 μM and 0.009 μM for CDK2 and CDK9, respectively. It induces apoptosis by regulating G2/M cell cycle arrest and exhibits antitumor activity.
    Formule :C14H14N6O2S2
    Couleur et forme :Solid
    Masse moléculaire :362.43

    Ref: TM-T204166

    10mg
    À demander
    50mg
    À demander
  • Topoisomerase I/II inhibitor 3


    Topoisomerase I/II inhibitor 3 suppresses cell growth and induces apoptosis in liver cancer by blocking PI3K/Akt/mTOR.
    Formule :C24H24N2O4
    Couleur et forme :Solid
    Masse moléculaire :404.46

    Ref: TM-T61990

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • PARP1/BRD4-IN-2


    PARP1/BRD4-IN-2, a potent inhibitor of PARP1 and BRD4, halts cell cycle, triggers apoptosis, and has antitumor effects on TNBC.
    Formule :C25H20N4O4
    Couleur et forme :Solid
    Masse moléculaire :440.45

    Ref: TM-T62540

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • EGFR-IN-45


    EGFR-IN-45: Strong EGFR/CDK2 inhibitor (IC50s: 0.4 & 1.6 μM), halts cancer cell cycle pre-G1, prompts apoptosis, also targets Topo I/II.
    Formule :C28H23N7O
    Couleur et forme :Solid
    Masse moléculaire :473.53

    Ref: TM-T63070

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Antiproliferative agent-8


    Compound 5a, an anticancer agent, enhances P53 and has antiproliferative effects.
    Formule :C22H16ClN3O3
    Couleur et forme :Solid
    Masse moléculaire :405.83

    Ref: TM-T62012

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • RET-IN-1

    CAS :
    RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively).
    Formule :C29H31N9O3
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :553.61

    Ref: TM-T16735

    25mg
    2.403,00€
    50mg
    3.240,00€
    100mg
    4.304,00€
  • Bayer-18

    CAS :
    Bayer-18 is an inhibitor of TYK2. It inhibits the viability of anaplastic large cell lymphoma cells, including K299, SR786, Mac1, and Mac2a, with an IC50 ranging from 2-3 µM. Additionally, Bayer-18 induces apoptosis in K299 and SR786 cells.
    Formule :C19H27FN6O2
    Couleur et forme :Solid
    Masse moléculaire :390.46

    Ref: TM-T200632

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Topo I-IN-1


    Topo I-IN-1 (14d) is a powerful Topo I inhibitor with antitumor effects and DNA intercalation, inducing apoptosis.
    Formule :C20H14BrN3O2
    Couleur et forme :Solid
    Masse moléculaire :408.25

    Ref: TM-T62048

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • Antiproliferative agent-4


    Antiproliferative agent-4 suppresses cancer cell growth with low toxicity, inhibits tumors in mice, and induces apoptosis in EC109 cells.
    Formule :C29H35ClO8
    Couleur et forme :Solid
    Masse moléculaire :547.04

    Ref: TM-T63864

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • MNK1/2-IN-6


    MNK1/2-IN-6: Strong, selective MNK1/2 inhibitor; IC50s: MNK1 at 2.3 nM, MNK2 at 3.4 nM; triggers dose-dependent apoptosis.
    Formule :C27H24N6O
    Couleur et forme :Solid
    Masse moléculaire :448.52

    Ref: TM-T62686

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • ERK-MYD88 interaction inhibitor 1

    CAS :
    <p>ERK-MYD88 Interaction Inhibitor 1, an agent that disrupts the interaction between ERK and MYD88, has demonstrated the ability to trigger an HRI-mediated integrated stress response (ISR) that specifically promotes immunogenic cell apoptosis (apoptosis) in cancer cells. Additionally, in models using Lewis lung cancer mice, this compound has been shown to stimulate anti-tumor T cell responses, thereby exhibiting significant anti-tumor activity.</p>
    Formule :C22H21N5O2
    Couleur et forme :Solid
    Masse moléculaire :387.43

    Ref: TM-T200225

    25mg
    1.444,00€
    50mg
    1.882,00€
    100mg
    2.375,00€
  • BNN27

    CAS :
    BNN27 is an agonist of the TrkA receptor (TrkAreceptor) and the p75NTR receptor (p75NTR receptor), exhibiting neurotrophic and anti-apoptotic properties. It enhances levels of glutamate, GABA, and glutamine in the hippocampus and prefrontal cortex of rats, improving glutamate turnover. In a mouse model of amyotrophic lateral sclerosis (ALS), BNN27 demonstrates neuroprotective effects, shows anti-inflammatory properties in an experimental autoimmune encephalomyelitis (EAE) model, and exhibits retinal protection in a rat diabetes model. BNN27 also possesses blood-brain barrier permeability.
    Formule :C21H32O3
    Couleur et forme :Solid
    Masse moléculaire :332.477

    Ref: TM-T204974

    10mg
    À demander
    50mg
    À demander
  • SL-176

    CAS :
    SL-176, a WIP1 inhibitor, when combined with GSK-J4, can induce cell cycle arrest and apoptosis (apoptosis), thereby inhibiting tumor growth both in vitro and in vivo.
    Formule :C24H48O4Si2
    Couleur et forme :Solid
    Masse moléculaire :456.806

    Ref: TM-T206776

    10mg
    À demander
    50mg
    À demander
  • Microtubulin-IN-1

    CAS :
    Microtubulin-IN-1 (Compound 8g) is an inhibitor of microtubulin, targeting the colchicine-binding site to disrupt tubulin integrity and induce upregulation of p53 protein expression. It exhibits antiproliferative activity across various cancer cell lines, including NCI-H460, BxPC-3, and HT-29, with IC50 values of 2.4, 1.6, and 2.07 nM, respectively. Additionally, Microtubulin-IN-1 induces cell cycle arrest at the G2/M phase and apoptosis in NCI-H460 cells.
    Formule :C25H21FN4O3
    Couleur et forme :Solid
    Masse moléculaire :444.458

    Ref: TM-T206493

    10mg
    À demander
    50mg
    À demander
  • CAR-2

    CAS :
    <p>CAR-2 is a BODIPY-based photosensitizer that induces ferroptosis in photodynamic therapy (PDT) by targeting the endoplasmic reticulum (ER) and lipid droplets (LD). It exhibits phototoxicity against breast cancer cells with an IC50 of 0.01-0.02 μM and demonstrates antitumor efficacy in a 4T1 xenograft mouse model.</p>
    Formule :C27H23BF2I2N4O2
    Couleur et forme :Solid
    Masse moléculaire :738.114

    Ref: TM-T205603

    10mg
    À demander
    50mg
    À demander